During the past decade, Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University" #1 collaborator was "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 1 trials as a collaborator, "D1 Medical Technology (Shanghai) Co., Ltd, China" with 1 trials as a collaborator, "Huadong Hospital" with 1 trials as a collaborator, "Nanfang Hospital of Southern Medical University" with 1 trials as a collaborator and "Qilu Hospital of Shandong University" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University" are "Neuroendocrine Neoplasm" (2 trials), "Pancreatic Cancer" (2 trials), "Surgery" (2 trials), "Borderline Resectable Pancreatic Cancer" (1 trials) and "Carcinoma, Pancreatic Ductal" (1 trials). Many other conditions were trialed in "Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University" in a lesser frequency.

Most popular intervention types in "Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University" are "Drug" (6 trials), "Procedure" (5 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Biopsy, open or laparoscopic surgery" (1 trials), "Biopsy/surgical tissue and peripheral blood" (1 trials), "Fruquintinib,Albumin Paclitaxel,Gemcitabine" (1 trials), "Metformin or insulin treatment" (1 trials) and "Minimally invasive radical pancreatectomy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University". 2 are not yet recruiting, 8 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".